(Q50545368)

English

Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.

scientific article published on 15 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Arturo Pereira

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Meritxell Nomdedeu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Josep-Lluís Aguilar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mohamed Belkaid

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Francesc Cobo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Dolors Costa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cristina Sanz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Benet Nomdedeu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

15 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

86

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

245-250

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328437%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

How I treat patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

The deleterious effects of iron overload in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Myelodysplasia paranoia: iron as the new radon

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Iron chelation therapy in myelodysplastic syndrome - Cui bono?

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Equivalence of the mediation, confounding and suppression effect.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Tutorial in biostatistics: competing risks and multi-state models

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Clinical consequences of red cell storage in the critically ill.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Myelodysplastic Syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Iron in the heart

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21959

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50545368&oldid=1709599812"